Crinetics

CRNX | NASDAQ | 0 Followers
$30.51 -0.03% -$0.01
Follow
Overview Metrics Financials
Loading...

Fair Price

$40.37
Overvalued by 86.7%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Crinetics Pharmaceuticals, Inc. is a biotechnology company focused on developing therapeutics for the treatment of endocrine and metabolic disorders. The company specializes in discovering and developing new drugs that modulate G-protein-coupled receptors, which are key mechanisms for regulating hormonal signaling in the body. Crinetics focuses on developing treatments for diseases such as acromegaly (caused by excessive growth hormone secretion), Cushing’s disease, and other hormonal disorders. The company's goal is to provide innovative treatment options for patients with these rare conditions.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade